Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1997 Feb;120(5):917–925. doi: 10.1038/sj.bjp.0700974

Cellular localization of the inhibitory action of abruquinone A against respiratory burst in rat neutrophils

Mei F Hsu *, Shue L Raung , Lo T Tsao , Sheng C Kuo , Jih P Wang ‡,*
PMCID: PMC1564537  PMID: 9138699

Abstract

  1. The possible mechanisms of action of the inhibitory effect of abruquinone A on the respiratory burst in rat neutrophils in vitro was investigated.

  2. Abruquinone A caused an irreversible and a concentration-dependent inhibition of formylmethionyl-leucyl-phenylalanine (fMLP) plus dihydrocytochalasin B (CB)- and phorbol 12-myristate 13-acetate (PMA)-induced superoxide anion (O2.−) generation with IC50 values of 0.33±0.05 μg ml−1 and 0.49±0.04 μg ml−1, respectively.

  3. Abruquinone A also inhibited O2 consumption in neutrophils in response to fMLP/CB and PMA. However, abruquinone A did not scavenge the generated O2.− in xanthine-xanthine oxidase system and during dihydroxyfumaric acid (DHF) autoxidation.

  4. Abruquinone A inhibited both the transient elevation of [Ca2+]i in the absence of [Ca2+]o (IC50 7.8±0.2 μg ml−1) and the generation of inositol trisphosphate (IP3) (IC50 10.6±2.0 μg ml−1) in response to fMLP.

  5. Abruquinone A did not affect the enzyme activities of neutrophil cytosolic protein kinase C (PKC) and porcine heart protein kinase A (PKA).

  6. Abruquinone A had no effect on intracellular guanosine 3′ : 5′-cyclic monophosphate (cyclic GMP) levels but decreased the adenosine 3′ : 5′-cyclic monophosphate (cyclic AMP) levels.

  7. The cellular formation of phosphatidic acid (PA) and phosphatidylethanol (PEt) induced by fMLP/CB was inhibited by abruquinone A with IC50 values of 2.2±0.6 μg ml−1 and 2.5±0.3 μg ml−1, respectively. Abruquinone A did not inhibit the fMLP/CB-induced protein tyrosine phosphorylation but induced additional phosphotyrosine accumulation on proteins of 73–78 kDa in activated neutrophils.

  8. Abruquinone A inhibited both the O2.− generation in PMA-activated neutrophil particulate NADPH oxidase (IC50 0.6±0.1 μg ml−1) and the iodonitrotetrazolium violet (INT) reduction in arachidonic acid (AA)-activated cell-free system (IC50 1.5±0.2 μg ml−1).

  9. Collectively, these results indicate that the inhibition of respiratory burst in rat neutrophils by abruquinone A is mediated partly by the blockade of phospholipase C (PLC) and phospholipase D (PLD) pathways, and by suppressing the function of NADPH oxidase through the interruption of electron transport.

Keywords: Abruquinone A, rat neutrophil, superoxide anion, inositol phosphate, protein kinase C, cyclic AMP, phospholipase D, tyrosine phosphorylation, NADPH oxidase, electron transport

Full Text

The Full Text of this article is available as a PDF (643.4 KB).


Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES